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Abstract
The aim is to study morphofunctional structure of NALT (nasal associated lymphoid tissue) and visceral lymph nodes of 
rats with experimental type 1 diabetes mellitus (DM-1) and to define the effectiveness of the treatment with herbal drug “Imupret”.
Materials and methods: The experiment involved 20 animals, divided into 4 groups: the 1st group was the control group 
of healthy rats, the 2nd group was the control group subject to prophylactic treatment with “Imupret, the 3rd group included rats with 
experimental diabetes, and the 4th group included rats with experimental diabetes subject to treatment with “Imupret. Functional 
changes in immune organs were evaluated by the results of morphometric analysis; morphological pattern was evaluated by histo-
structural changes. 
Results. The research revealed that under conditions of diabetes mellitus type 1, the volume, area and density of the lymphoid 
tissue decreased, and only its “fine” cell was detected. The paper demonstrates the development of relative immune deficiency in 
immunocompetent organs in rats with diabetes mellitus type 1. The use of drug “Imupret” demonstrated its immunomodulatory 
function, which is especially important in terms of immunosuppression in patient with DM-1. 
Conclusion. The received results are of a great clinical significance, and show the necessity of early prevention and treatment 
of immunity disorders under conditions of diabetes mellitus type 1. 
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1. Introduction
In recent years, within increase of prevalence of immunodeficiency states of different genesis, 
doctors’ interest in the immune system functioning increased significantly [1]. The immune system 
is known to have a close connection with the endocrine system, and is particularly affected under 
condition of such disease as diabetes mellitus type 1 (DM-1) [2]. Increased susceptibility to infections 
in patients with DM-1 is associated with impaired protective functions of the body as a result of sup-
pressed immunity, enhanced cell adhesion of microorganisms, a tendency to catabolic processes. In 
the pathogenesis of DM-1 and many of its complications, an important place belongs to the violation 
of the functional capacity of the immune system, which is the subject of numerous studies [3]. In pa-
tients with diabetes mellitus, significant changes appears in chemotaxis, a decrease in the bactericidal 
activity of neutrophils, increased production of reactive oxygen species, leukotrienes, secretion of 
lysosomal enzymes, and changes in the level of intracellular calcium are often observed [4]. 
Morphological basis of the immune system is a lymphoid tissue, which is represented by the 
central and peripheral organs [5]. The structures protecting the mucous membrane are called mucosa 
associated lymphoid tissue – MALT. MALT consists of visceral lymph nodes of gastrointestinal tract, 
being the place to induce humoral (antibody mediated) and cellular immunity [6]. The analogue of such 
tissue in the conducting airway is the nasal-associated lymphoid tissue (NALT) or lymphoid tissue asso-
ciated with the nasal cavity, which is the regional representative of submucosal of the immune system. It 
is localized as adjacent to the nasal mucosa and mucosa of the soft palate. NALT is inherent both to hu-
mans and rats, but the rats do not have tonsils; thus NALT for rats can be considered as the first immune 
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barrier to fight against external antigens in the digestive and respiratory systems [7]. In contrast to the 
well-characterized Peyer’s patches, which are already present in fetal life and seem to be a constitutive 
part of the integrated mucosal immune system, the tissue genesis of NALT is different [8]. So far no data 
on NALT formation during embryogenesis in humans are available, but in rats and mice NALT has been 
observed only postnatal [9]. In fetal human larynges there is only a scattered distribution of immuno-
competentcells, but no organized larynx-associated lymphoid tissue (LALT) [10]. Bronchus-associated 
lymphoid tissue (BALT) is sometimes present in the fetus, but associated mainly with infections, and 
develops after birth [11]. In the non-infected fetus BALT is found only rarely and in low density [12]. 
Therefore, the formation of respiratory MALT seems to be a reactive phenomenon in response to mi-
crobial stimulation. Dysregulation of mucosal immune responses might be a critical factor in the still 
unknown etiology of sudden infant death syndrome (SIDS) [13]. No data are available so far on the 
occurrence of NALT in human adults, as NALT is difficult to investigate in this age group because cal-
cification inhibits adequate sampling and processing of tissue blocks [14]. MALT is characterised by the 
predominance of local dimeric IgA production, secreted as secretory IgA (sIgA) that is responsible for 
the immune exclusion of bacteria and viruses [15]. The term common mucosal immune system (CMIS) 
implies that activated lymphocytes derived from one mucosal surface can recirculate and localise se-
lectively in other mucosal surfaces [16]. This connection between different mucosal surfaces permits 
immunity initiated at one anatomical site to protect other mucosal sites [17]. In rats, NALT is present at 
birth, earlier than BALT and this is probably due to its strategic position with respect to the incoming 
air [18]. As rats are obligate nasal breathers, the inspired air, laden with environmental antigens, passes 
the nasal cavities before it reaches the lungs. [19]. The particular interest from the point of view of clin-
ical effectiveness has the combined herbal preparation BNO 1030 (Imupret) [20].
2. Aim of research
To study morphofunctional structure of NALT (nasal associated lymphoid tissue) and vis-
ceral lymph nodes of rats with experimental type 1 diabetes mellitus (DM-1) and to define the 
effectiveness of the treatment with herbal drug “Imupret”.
3. Material and methods
The research involved intact Wistar male rats (20 animals in total), weighing 130−150 grams, 
under the conditions of experimental diabetes mellitus type 1. Experimental DM-1 for rats was in-
duced by a single intraperitoneal introduction of Streptozotocin (S0130, Sigma-Aldrich Co. LLC, 
the USA), dose of 55.0 mg/kg, diluted in 0.1 M citrate buffer, pH 4.5. Rats of the same age in the 
control group got intraperitoneally 0.5 ml of 0.1 M citrate buffer, pH 4.5. After four weeks of diabe-
tes development, within 14 days, rats got drug Imupret per os 0.05 ml/animal three times a day; cho-
sen concentration meets guidelines for use of the daily dose for children over 12 years and adults, 
taking into account the factors of species stability for human and rats (0.45 and 1.89 respectively). 
Functional changes in immune organs were evaluated by the results of morphometric analysis. 
Qualitative histostructural changes were detected (such as appearance of germinal centers in lym-
phoid tissue nodules, changes in the density of lymphoid tissue); quantitative parameters were sub-
ject to statistical evaluation. Micro photographs were obtained using microscope Olympus BX 51. 
Morphometric analysis was performed with Carl Zeiss software (AxioVision SE64 Rel. 4.9.1), 
magnification ×400. All rats were divided in 4 groups, 5 animals in each one: the 1st group was the 
control group of healthy rats, the 2nd group was the control group subject to prophylactic treatment 
with “Imupret”, the 3rd group included rats with experimental diabetes, and the 4th group included 
rats with experimental diabetes subject to treatment with “Imupret”.
4. Results
Visceral nodes in the control group of intact rats showed the normal morphological picture. 
NALT is small and has no signs of immune activation (Fig. 1, a−c). In cortical substance (Fig. 1, a) 
were registered lymphoid follicles, and moderate density lymphocytes were recorded in reticulo-
endothelial cells. In medulla (Fig. 1, b) was registred a small number of lymphocytes and stromal 
elements of reticuloendothelial cells.
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                       a                                                 b                                                      c
Fig. 1. Lymph node of control group: a − cortical substance; b – medulla.  
Note:  − lymphocytes;  − macrophages;  − reticuloendothelial cells.  
Hematoxylin-eosin; c − Nasal-associated lymphoid tissue (NALT). 
* − Clusters of lymphocytes NALT. Toluidine blue
In rats with DM-1 we found the sings of reactive immune activation. In cortex of visceral 
nodes were registered lymphoid follicles, moderate density lymphocyte, activation of reticuloen-
dotheliocytus, in medulla we found a small number of lymphocytes and stromal elements of re-
ticuloendotheliocytus. In NALT it has been shown significant number of neutrophils and isolated 
basophils. (Fig. 2, a−c).
             a                                                      b                                                      c
Fig. 2. Lymph node of diabetic rats. a − cortical substance, b – medulla.  
Note:  − lymphocytes; GC − germinal center (lymphoid reaction);  − cell in mitosis;   
 − r eticuloendothelial cells. Hematoxylin-eosin; c − Nasal-associated lymphoid tissue (NALT). 
Note:  − tissue basophils;  − neutrophils; * − Clusters of lymphocyte NALT. Toluidine blue. 
In diabetic rats, which were treated with Imupret, were found the signs of immune response. 
It was registered the increased density of lymphocytes, activation of mitosis and germinal center 
(Fig. 3, a, b). 
                              a                                                                       b
Fig. 3. Lymph node of diabetic rats, which received Imupret. a – cortical substance; b – medulla. 
Note:  – lymphocytes; GC – germinal center (lymphoid reaction);  
 – cell in mitosis;  – reticuloendothelial cells
   
*
    
* 
      
GC 
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5. Discussion
Within the study of visceral nodes the control group of intact rats showed no inflammatory 
changes, signs of antigen presentation. The stromal elements of medulla, brain cords, and capsules 
showed no signs of reorganization. Only a few macrophages were recorded within the field of view. 
The volume of NALT was insignificant; in addition, there were recorded the tissue basophils with-
out the signs of degranulation (Fig. 1, a–c).
Within the study of visceral lymph nodes, the group with diabetes showed reactive chang-
es of lymph node stroma; at morphological level it was manifested in the increasing number 
of epithelioreticular cells, increase of volume indicators (size of the nuclei and soma). Sinus-
es of the node showed an increase in the lymphoid cells density, from a moderate increase in 
the lymphocytes number (especially in individual sinuses) up to occurrence of the secondary 
nodes with clear germinal centers, being a manifestation of migration of B-lymphocytes and 
AG-presentation. The cells in mitosis were detected, which could indicate both the migration of 
immunocompetent cells, and their proliferation. Medullary substance also showed an increase in 
the lymphoid cells density as well as epithelioreticular cells and occurrence of groups of macro-
phages. These changes can be assessed as a manifestation of activation of the immune response, 
and as for the stromal elements, reorganization of the stroma in response to a volume increase of 
lymphoid tissue representation Fig. 2, a, b.
The study of NALT in diabetic group of rats detected only its small focus with accumulation 
of groups of neutrophils and isolated basophils (Fig. 2, c).
The group of rats with diabetes mellitus, treated with herbal drug “Imupret”, showed in the 
visceral lymph nodes the appearance of significant germinal centers in the cortex of the lymph 
nodes, significant increase in the lymphocytes density, as well as isolated cells in mitosis. Medul-
lary substance showed the cords of lymphoid cells, increase of lymphocytes density in the dural 
and portal sinuses (Fig. 3, a, b). 
The results of the research found out that morphological and functional state of lymphoid 
tissue is closely related to glucose metabolism. It revealed the signs of immunodeficiency among 
affected rats, both in visceral lymph nodes, and in NALT (p<0,05). In this group, morphometric 
analysis showed the increased number of epithelioreticular cells, increase of volume indicators 
(size of the nuclei and soma). Despite a wide range of antidiabetic drugs used in the clinic of DM-1 
and its complications, now more attention is paid to the use of phytotherapy. One of the widely used 
phytopreparations at present is the Imupret, the mechanism of its action is not completely clarified. 
In diabetic group of rats, which received Imupret, we demonstrated increased lymphocytes 
density in visceral lymph nodes and NALT (p<0,05).
6. Conclusions
1. The studied structures, i. e., visceral lymph nodes and NALT refer to the peripheral lym-
phoid organs; they have a similar structure, shown within the study of their histology. 
2. The research demonstrated the changes in these organs in rats with DM-1, induced with 
Streptozotocin. It revealed the signs of immunodeficiency among affected rats, both in visceral 
lymph nodes, and in NALT. 
3. Use of drug “Imupret” demonstrated its immunomodulatory function (p<0,05), which is 
especially important in terms of immunosuppression in patient with DM-1.
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